Skip to main content
icon-search-14x14

Adrian Packer

  • Associate | M&A and Private Equity

London

T: +44.20.7972.9212

Adrian Packer concentrates on mergers and acquisitions and private equity. Adrian represents corporates and private equity houses on a wide spectrum of cross-border transactions.  

Adrian’s corporate practice includes experience advising on public and private disposals and acquisitions, as well as capital markets transactions, minority investments, and other general corporate advisory matters.

Having trained at Fried Frank, Adrian qualified into the London M&A and Private Equity team in 2020.

Work highlights:

  • LumiraDx Limited on its $3 billion de-spac merger with CA Healthcare Acquisition Corp and its NASDAQ listing.
  • Domino's Pizza Group plc (DPG) on the sale of Domino's Pizza GmbH, the holder of the Domino's master franchise rights in Switzerland (Domino's Switzerland), as well as the sale of DPG's business in Sweden, Iceland and Norway. All were through auction sales.
  • LumiraDx Limited on numerous debt and equity fundings including (i) raising up to $350 million through a Preferre...

Adrian Packer concentrates on mergers and acquisitions and private equity. Adrian represents corporates and private equity houses on a wide spectrum of cross-border transactions.  

Adrian’s corporate practice includes experience advising on public and private disposals and acquisitions, as well as capital markets transactions, minority investments, and other general corporate advisory matters.

Having trained at Fried Frank, Adrian qualified into the London M&A and Private Equity team in 2020.

Work highlights:

  • LumiraDx Limited on its $3 billion de-spac merger with CA Healthcare Acquisition Corp and its NASDAQ listing.
  • Domino's Pizza Group plc (DPG) on the sale of Domino's Pizza GmbH, the holder of the Domino's master franchise rights in Switzerland (Domino's Switzerland), as well as the sale of DPG's business in Sweden, Iceland and Norway. All were through auction sales.
  • LumiraDx Limited on numerous debt and equity fundings including (i) raising up to $350 million through a Preferred Share issue (such investors including the Bill and Melinda Gates Foundation, CVS, Morningside, Danaher and Thermo Fisher), (ii) raising $150 million to fund its COVID-19 antigen and antibody tests.
  • AEA on its acquisition of Red Global (including in relation to the management equity plan).
  • Permira: leading the $180 million Series B funding round for GWI, valuing the company at $850 million.
Back to top ↑

Email Disclaimer

I have read and understood the terms of use of this web site which appear below, and specifically agree to those terms, on behalf of myself and anyone else on whose behalf I am contacting anyone at Fried Frank using this site or in any way connected with this site:

The information and materials offered on this site are for general informational purposes only, do not constitute and should not be considered to be legal advice, and are presented without any representation or warranty whatsoever, including as to the accuracy or completeness of the information. No one should, or is entitled to, rely in any manner on any of the information at this site. Parties seeking advice should consult with legal counsel familiar with their particular circumstances.

Prior results do not guarantee a similar outcome.

No attorney-client relationship is created by our transmission of information from this site or by any communication by others to us (or to any of our attorneys, staff, employees, agents or representatives) through or in any way connected with this site. Users communicating with us (or to any of our attorneys, staff, employees, agents or representatives) are cautioned that we do not undertake to hold such communications or their contents in confidence and, accordingly, that they should be careful not to communicate confidential information to us. Users are further cautioned that we may represent a party directly adverse to them either now or at a later date, and that we remain free to do so notwithstanding any information which is communicated to us by the user or any other person or any solicitation of our services by the user or any other person. An attorney-client relationship between Fried Frank and users of this site or anyone else is created only by a written engagement letter signed by a partner of Fried Frank, and no course of communication shall constitute an undertaking to receive confidential information in connection with a discussion of possible future representation unless such undertaking is contained in a written letter agreement signed by a partner of Fried Frank specifying the conditions of such receipt and countersigned by a person with authority to bind the prospective client.

Links to information on sites other than those operated by, or on behalf of, Fried Frank are for your convenience only and are not an endorsement or recommendation of those sites. Fried Frank does not take any responsibility for information at these sites, nor makes any representation or warranty with respect to these sites or their information.

By clicking "Accept", I specifically agree to these terms, on behalf of myself and anyone else on whose behalf I am contacting anyone at Fried Frank.